CRISTINA
ESTORNUT NAVARRO
INVEST FORMACION PROMETEO
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (2)
2022
-
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
Cancers, Vol. 14, Núm. 5
-
Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model
International Journal of Molecular Sciences, Vol. 23, Núm. 3